Dignity Health + CancerIQ: Keeping patients connected to telegenetics—during and beyond Covid-19

Covid-19 ground routine cancer screening and risk assessments to a halt. As a result, many programs are concerned about delayed detection of cancers, which could be exacerbated over the next few months by patients' reluctance to come into health care facilities. Dignity Health has leveraged their virtual genetic counseling services and long-standing partnership with CancerIQ, a genetic cancer risk assessment platform, to continue screening patients for their genetic risk of cancer-a strategy that not only supports patients during the Covid-19 pandemic but will continue to maximize staff efficiencies as "non-essential" services ramp back up.